For the quarter ending 2026-03-31, AEVA had -$57,939K decrease in cash & cash equivalents over the period. $67,954K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|
| Net loss | 85,135 | 107,495 | -227,609 |
| Depreciation and amortization | -2,729 | 1,337 | 2,716 |
| Loss on joint development agreement | - | 0 | 3,785 |
| Impairment of inventories | -493 | 359 | 134 |
| Change in fair value of warrant liabilites | -25,804 | -68,524 | 93,878 |
| Other | - | 0 | 0 |
| Stock-based compensation | -7,163 | 5,940 | 10,588 |
| Fair value loss on share subscription liability | - | - | -69,996 |
| Amortization of right-of-use assets | -1,993 | 724 | 1,830 |
| Amortization of premium and accretion of discount on available-for-sale securities, net | 422 | -112 | -795 |
| Accretion of convertible notes issuance cost | 100 | - | - |
| Accounts receivable, net | -667 | -1,950 | 2,709 |
| Inventories | -2,900 | 1,649 | 1,448 |
| Other current assets | -713 | -265 | -2,849 |
| Other noncurrent assets | -279 | 204 | -505 |
| Accounts payable | 1,263 | 268 | -1,779 |
| Accrued liabilities | -797 | 3,577 | -2,940 |
| Other noncurrent liability | - | -957 | 1,472 |
| Accrued employee costs | -3,889 | 1,127 | -3,337 |
| Lease liability | 1,957 | -462 | -1,932 |
| Other current liabilities | 20,812 | -13,450 | -5,820 |
| Net cash used in operating activities | 67,080 | -32,312 | -60,616 |
| Purchase of property, plant and equipment | -874 | 1,274 | 1,825 |
| Purchase of available-for-sale securities | 11,213 | 2,179 | 23,369 |
| Proceeds from maturities of available-for-sale securities | -87,849 | 27,200 | 79,149 |
| Net cash provided by investing activities | -98,188 | 23,747 | 53,955 |
| Proceeds from equity-related funding in connection with the jda | -27,000 | 32,500 | - |
| Payments of taxes withheld on net settled vesting of restricted stock units | -578 | 0 | 578 |
| Payment of convertible notes issuance cost | 297 | - | - |
| Proceeds from exercise of stock options | -112 | 10 | 118 |
| Net cash provided by (used in) financing activities | -26,831 | 32,510 | -460 |
| Net decrease in cash and cash equivalents | -57,939 | 23,945 | -7,121 |
| Beginning cash and cash equivalents | 26,603 | 28,864 | - |
| Ending cash and cash equivalents | -14,512 | 45,688 | - |